Pleural effusion refers to the abnormal buildup of fluid between the lung and chest wall, caused by conditions ranging from infections and heart failure to malignancy. Patients may present with chest heaviness, shortness of breath, or persistent cough, though small effusions may remain asymptomatic and discovered only on imaging. A diagnostic workup for pleural effusion includes chest radiography, ultrasound, and thoracentesis to evaluate the nature of the fluid and guide treatment. Identifying whether the fluid is transudative or exudative is crucial to uncovering underlying causes, which may include systemic disease, local infection, or tumor involvement.
Management strategies depend on both the underlying condition and the severity of symptoms. Therapeutic thoracentesis provides immediate relief from breathlessness, while indwelling pleural catheters or pleurodesis are options for recurrent cases. Treating the primary cause—whether with antibiotics for infection, diuretics for heart failure, or oncologic therapies for malignancy—remains central to long-term resolution. Advances in imaging and minimally invasive procedures are improving safety and precision in both diagnosis and management. Careful follow-up ensures monitoring for recurrence, progression, or complications. With timely intervention, pleural effusion can often be managed effectively, restoring comfort and supporting better respiratory function.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation